News

June 2 (Reuters) - Shares of Fulcrum Therapeutics (FULC.O), opens new tab plunged 52% on Tuesday after the company said it would abandon development ​of its…

CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206SHANGHAI, June 2, 2026 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (…

The drug, pociredir, was being developed as an ​oral treatment for sickle-cell disease, an inherited blood disorder that can cause ​pain, anemia, organ damage and…

CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206SHANGHAI, June 2, 2026 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (…

― Decision follows FDA feedback regarding the implications of the secondary malignancies observed with Tazverik®(tazemetostat) and the product’s subsequent global…

AbstractAlloimmunisation is a notorious dilemma in blood transfusion intervention therapy, especially in low-resource countries, and studies have shown that…

AbstractSickle cell disease (SCD) is a major global health burden, and early, accurate diagnosis is critical for effective management. Conventional diagnostic…

Health Minister Y. Satya Kumar on Friday said that the State government is committed to strengthening healthcare infrastructure and improving medical services in…

Agios Pharmaceuticals’ next-gen pyruvate kinase (PK) activator has failed a phase 2 study in a group of rare blood cancers, although the biopharma is still holding…

AbstractBackground: Sickle cell anemia (SCA) is a genetic disease marked by abnormal hemoglobin S and sickle-shaped red blood cells. It is highly prevalent in sub-…